Twist Bioscience prices upsized USD 300 million common stock offering at USD 96 per share
Reuters2026/08/05 03:45- Twist Bioscience priced an upsized underwritten follow-on offering of 3,125,000 common shares at USD 96 per share.
- Gross proceeds expected at USD 300 million; closing targeted for Aug. 6, 2026, subject to customary conditions.
- Underwriters hold a 30-day option to buy up to 468,750 additional shares at the offering price, less discounts and commissions.
- Proceeds earmarked for R&D, manufacturing expansion, product offerings, working capital, general corporate purposes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Euro holds gains above 1.1600 despite robust US jobs data, traders eye ECB rate decision
Port of Tauranga wins fast-track approval for Stella Passage development
The first major "exam" after the Cook era! Morgan Stanley: Apple's (AAPL.US) autumn launch event is the most important in ten years; the first foldable iPhone may spark a new wave of growth
Morgan Stanley analysts stated that Apple's upcoming "Surprise and Shine" autumn product launch event on September 9 may become the company's most important product release in nearly a decade.
Crypto prices
More
